New Delhi: YouTube Music has marked its 10 years of journey in the music application industry, and they have introduced a new set of features, which is now the direct rivalry for Spotify, because YouTube wanted to make a mark that they tried to beat Spotify, and wanted to be in the No.1 position. The application will now include Taste Match playlists, which are playlists that will combine multiple users by overlapping interests, similar to the Spotify Blend. This application will also start notifying the users of upcoming releases, merch, and concerts, and is partnering with Bandsintown to help fans discover concerts when watching videos and Shorts on YouTube itself.
Additionally, it will help YouTube catch up with rival Spotify in some areas, while others, like the addition of badges and support for commenting, will extend the social networking features of YouTube to the music service. The company also shared the latest stats about YouTube Music’s catalogue; it now has over 300 million tracks, including studio recordings, live performances, remixes, and covers. Spotify, for comparison, has over 100 million tracks. YouTube says its music service offers over 4 billion music-focused user-generated playlists, 1.8 billion of which are public.
With the latest Taste Match playlists, YouTube Music users can combine their interests into a single playlist that updates daily, featuring tracks that are based on the music tastes of everyone who joins the YouTube Music application. YouTube Music users are now able to leave comments on the albums and playlists directly, to make listening more of a social experience. Fans will be able to earn loyalty badges like First to Watch or Top Listener, with the others still on the way. Artists and bands, meanwhile, can work toward music video watch milestones, like 100,000 views, 1 million, or even 1 billion views.
YouTube’s Music service continues to grow, having gone from 100 million subscribers in February 2024 to over 125 million across the YouTube Music and YouTube Premium combined as of March 2025, including trials.
